RSS Coordinator(s):
  • Ranee Williams-Toycen
Series date: 
07/01/2020 - 7:30am CDT to 06/30/2022 - 11:59pm CDT

Series Overview

This is a multidisciplinary tumor board that has run weekly for many years. It includes head and neck surgeons, radiation oncologists, medical oncologists, neuroradiologists, pathologists, advanced practice providers, nurses, social workers, and research coordinators. In general, the majority of new head and neck cancer patients' cases are discussed at the time of diagnosis to formulate a multidisciplinary plan. Generally, the providers who have seen the patient present their case, followed by discussion of radiologic and pathologic findings, which is then followed by a multidisciplinary discussion to generate a plan of care. Evidence for different approaches is discussed and a consensus plan is agreed to. 

Target Audience

MDs/DOs, RNs/APRNs, NPs, PAs, Social Workers, Dentists, and Students.

Planning Committee

Adam Burr, MD, PhD, Clinical DirectorGregory Hartig, MD, Planning Committee ChairLyndy Jainga, RN, Clinical Director, Coordinator
Justine Bruce, MDBenjamin Durkee, MD, PhDRong Hu, MD, PhD
Gregory Avey, MDTBD, Social WorkerAnnie Sugar, PA-C


Accreditation Statement

Jointly Accredited Provider LogoIn support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation Statements

American Medical Association (AMA)

The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)

The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.5 ANCC contact hour.  

ANCC pharmacotherapeutic contact hours will be calculated and awarded as appropriate per session to meet the needs of advanced practice nurses. 

AAPA Credit Designation Statement

The University of Wisconsin–Madison ICEP has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until 6/30/2022. PAs should only claim credit commensurate with the extent of their participation

ASWB Approved Continuing Education (ACE)

As a Jointly Accredited Organization, the University of Wisconsin–Madison ICEP is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program.  Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. University of Wisconsin–Madison ICEP maintains responsibility for this course. Social workers completing this course receive 1.5 live continuing education credits.

Continuing Education Units

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.15 continuing education units (CEUs) or 1.5 hours.


It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the  speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE).  In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity, all relevant financial relationships have been mitigated and detailed disclosures are listed below.

* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.

Detailed disclosures will be available prior to the start of the activity.

Disclosures for Planning Committee
Disclosures for Planning Committee - March 1, 2022 to June 30, 2022

Series location: 
United States
RSS Format: 
Case Conference
Live Stream Available: 
Global Objectives: 

As a result of participation in this educational series, participants will increase their ability to:

  1. Improve speed of sign-out, including SBAR documentation in health link
  2. Ensure prompt involvement of mental health and social work services in head and neck cancer care
  3. Improve utilization of palliative care resources
  4. Foster effective communication and teamwork among members of the interprofessional care team
  5. Reflect on health disparities and diverse clinical encounters in cancer care
Interprofessional RSS: 
Intended Audience: 
Nurse Practitioner
Physician Assistant
Social Worker
Other Health Professional
Hematology and Oncology
Credits Available: 
AAPA Category 1 CME
AMA PRA Category 1 Credit
ANCC Contact Hours
ANCC Pharmacotherapy Contact Hours
ACE Credits
University of Wisconsin–Madison Continuing Education Hours


Sessionsort descending Date
Head and Neck Tumor Board, June 22nd, 2022 06/22/2022 - 6:30am to 8:00am CDT
Head and Neck Tumor Board, June 29th, 2022 06/29/2022 - 6:30am to 8:00am CDT
Head and Neck Tumor Board, June 8th 06/08/2022 - 6:30am to 8:00am CDT
Head and Neck Tumor Board, March 16th, 2022 03/16/2022 - 6:30am to 8:00am CDT
Head and Neck Tumor Board, March 23rd, 2022 03/23/2022 - 6:30am to 8:00am CDT
Head and Neck Tumor Board, March 2nd, 2022 03/02/2022 - 6:30am to 8:00am CST
Head and Neck Tumor Board, March 30th, 2022 03/30/2022 - 6:30am to 8:00am CDT
Head and Neck Tumor Board, March 9th, 2022 03/09/2022 - 6:30am to 8:00am CST
Head and Neck Tumor Board, May 11th, 2022 05/11/2022 - 6:30am to 8:00am CDT
Head and Neck Tumor Board, May 18th, 2022 05/18/2022 - 6:30am to 8:00am CDT